Clinical Trial Update: A Study of Enasidenib in People With T-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating enasidenib in people with T-cell lymphoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Lymphoma

Drugs mentioned

• Enasidenib (enasidenib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: T-cell Lymphoma | Phase 2 | Status: RECRUITING